Stifel analysts maintained their Buy rating on Iovance Biotherapeutics (NASDAQ:IOVA), currently trading at $5.24, with a steady price target of $21.00. According to InvestingPro data, analyst targets ...

Stifel analysts increased their price target for Ecolab Inc . (NYSE:ECL) shares to $307.00, up from the previous $285.00, while reiterating a Buy rating on the stock. The company, currently valued at ...

Stifel analyst Paul Matteis lowered the firm’s price target on Biogen (BIIB) to $144 from $175 and keeps a Hold rating on the shares. The ...

Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...

"Opinions on Elon Musk have taken a turn for the worse along political affiliations," Stifel analyst Stephen Gengaro said.

MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...

GATX Corporation (NYSE: GATX) announced the cancellation of its presentation and webcast at the Stifel 2025 Transportation & ...

Stifel analysts lowered their price target for Tesla stock in response to “the negative downturn in consumers' perception of ...

Lattice Semiconductor (NASDAQ:LSCC – Get Free Report) had its price target boosted by Stifel Nicolaus from $65.00 to $70.00 in a report released on Tuesday,Benzinga reports. The firm presently has a ...

Over the past five years, Stifel has hired 450 advisors, with a cumulative trailing 12-month production of more than $350 million, according to CFO Marischen. That has driven the wealth division’s ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Stifel Financial Corp. provides securities brokerage, investment banking, trading, investment advisory and related financial services. It operates through the following segments: Global Wealth ...